A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

Zhou, Yadi, Hou, Yuan, Shen, Jiayu, Mehra, Reena, Kallianpur, Asha, Culver, Daniel A., Gack, Michaela U., Farha, Samar +10 more·2020·PLoS Biology

Cited by (181)

Items 101–181 of 181

  1. Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action
    AKM Azad, Shadma Fatima, Alexander Capraro, Shafagh A. Waters, Fatemeh Vafaee · 2021 · Patterns
  2. Pedagogy and innovative care tenets in COVID-19 pandemic: An enhancive way through Dentistry 4.0
    Mohd Javaid, Abid Haleem, Ravi Pratap Singh, Rajiv Suman · 2021 · Sensors International
  3. A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research
    Gergely Zahoránszky-Köhalmi, Vishal B. Siramshetty, Praveen Kumar, Manideep Gurumurthy, Busola Grillo, Biju Mathew, Dimitrios Metaxatos, Mark Backus, Tim Mierzwa, Reid Simon et al. · 2022 · Journal of Chemical Information and Modeling
  4. Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets
    Kuoyuan Cheng, Laura Martin-Sancho, Lipika R. Pal, Yuan Pu, Laura Riva, Xin Yin, Sanju Sinha, Nishanth Ulhas Nair, Sumit K. Chanda, Eytan Ruppin · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Shared molecular signatures between coronavirus infection and neurodegenerative diseases provide targets for broad-spectrum drug development
    Li Deng, Ling Ding, Xianlai Duan, Yousong Peng · 2023 · Scientific Reports
  6. Vitamin D Supplementation in Neonatal and Infant MIS-C Following COVID-19 Infection
    Manuela Rizzi, Vincenzo Avellis, Alessandro Messina, Chiara Germano, Elena Tavella, Valentina Dodaro, Raffaele Vitale, Alberto Revelli, Paolo Zola, Simonetta Picone et al. · 2024 · International Journal of Molecular Sciences
  7. Artificial Intelligence for Drug Discovery
    Jian Tang, Fei Wang, Feixiong Cheng · 2021 · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD)
  8. Deficient synthesis of melatonin in COVID-19 can impair the resistance of coronavirus patients to mucormycosis
    Amarnath Sen · 2021 · Medical Hypotheses
  9. COVID‐19 Metabolomic‐Guided Amino Acid Therapy Protects from Inflammation and Disease Sequelae
    Siqi Ming, Siying Qu, Yongjian Wu, Jia‐You Wei, Guoliang Zhang, Guanmin Jiang, Xi Huang · 2023 · Advanced Biology
  10. Network Medicine: From Conceptual Frameworks to Applications and Future Trends
    Enes Sefa Ayar, Sina Dadmand, Nurcan Tunçbağ · 2023 · IEEE Transactions on Molecular Biological and Multi-Scale Communications
  11. Accelerating Complex Disease Treatment Through Network Medicine and GenAI: A Case Study on Drug Repurposing for Breast Cancer
    Ahmed Abdeen Hamed, Tamer E. Fandy, Xindong Wu · 2024 · IEEE International Conference on Medical Artificial Intelligence (MedAI)
  12. Micronutrients for potential therapeutic use against COVID-19; a review
    Richard Giovane, Stephanie Kinsley, Emily Keeton · 2021 · Clinical Nutrition ESPEN
  13. Network Biology and Medicine to Rescue: Applications for Retinal Disease Mechanisms and Therapy
    Anupam K. Mondal, Anand Swaroop · 2023 · Advances in experimental medicine and biology
  14. Network-based approach for drug repurposing against mpox
    Kang Lai Tang, Qianru Sun, Jinfeng Zeng, Jing Yan Tang, Pei‐Wen Cheng, Zekai Qiu, Haoyu Long, Yilin Chen, Chi Zhang, Jie Wei et al. · 2024 · International Journal of Biological Macromolecules
  15. Circadian-driven tissue specificity is constrained under caloric restricted feeding conditions
    Renrui Chen, Ziang Zhang, Junjie Ma, Bing Liu, Zhengyun Huang, Ganlu Hu, Ju Huang, Ying Xu, Guang‐Zhong Wang · 2024 · Communications Biology
  16. Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19
    Philip L. Hooper · 2021 · Cell Stress and Chaperones
  17. The circadian rhythm of viruses and its implications on susceptibility to infection
    José Ramón Blanco, Eva M. Verdugo‐Sivianes, Ana Amiama-Roig, Sandra Muñoz-Galván · 2022 · Expert Review of Anti-infective Therapy
  18. Network modeling helps to tackle the complexity of drug–disease systems
    Maurizio Recanatini, Luca Menestrina · 2023 · WIREs Mechanisms of Disease
  19. Knowledge Mapping of Drug Repositioning’s Theme and Development
    Xiaona Lang, Jinlei Liu, Guangzhong Zhang, Xin Feng, Wen Dan · 2023 · Drug Design, Development and Therapy
  20. The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine Observation
    Jiayu Shen, Yuan Hou, Yadi Zhou, Reena Mehra, Lara E. Jehi, Feixiong Cheng · 2020 · Frontiers in Neuroscience
  21. Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
    Andrea Gelemanović, Tinka Vidović, Višnja Stepanić, Katarina Trajković · 2021 · Pharmaceuticals
  22. Network medicine analysis for dissecting the therapeutic mechanism of consensus TCM formulae in treating hepatocellular carcinoma with different TCM syndromes
    Kai Gao, Wanchen Cao, Zihao He, Liu Liu, Jincheng Guo, Lei Dong, Jini Song, Yang Wu, Yi Chen Zhao · 2024 · Frontiers in Endocrinology
  23. Non-Intrusive Assessment of COVID-19 Lockdown Follow-Up and Impact Using Credit Card Information: Case Study in Chile
    Ricardo Muñoz, Sebastián A. Ríos, Marcel Goić, Manuel Graña · 2021 · International Journal of Environmental Research and Public Health
  24. Looking at COVID-19 from a Systems Biology Perspective
    Emily Samuela Turilli-Ghisolfi, Marta Lualdi, Mauro Fasano · 2022 · Biomolecules
  25. Comprehensive Analysis of Ubiquitome Changes in Nicotiana benthamiana after Rice Stripe Virus Infection
    Yu Liu, Chenyang Li, Yaqin Wang, Yi Xu, Jianxiang Wu, Xueping Zhou · 2022 · Viruses
  26. Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference
    Jianhua Wang, Jiaojiao Liu, Menghan Luo, Hui Song Cui, Wenwen Zhang, Ke Zhao, Hong Dai, Fangfang Song, Kexin Chen, Ying Yu et al. · 2022 · iScience
  27. Integration of Omics Data and Network Models to Unveil Negative Aspects of SARS-CoV-2, from Pathogenic Mechanisms to Drug Repurposing
    Letizia Bernardo, Andrea Lomagno, Pierluigi Mauri, Dario Di Silvestre · 2023 · Biology
  28. Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
    Russel Joseph Reiter, Daniel Pedro Cardinali, Richard L. Neel, Alberto Domínguez Rodríguez, Gregory M D Brown, Jan Tesařík · 2021 · Melatonin Research
  29. Artificial Intelligence to Guide Repurposing of Drugs
    Zhimin Fu, Yuxin Yang, Mina K. Chung, Feixiong Cheng · 2026 · Annual Review of Medicine
  30. Drug Repurposing for COVID-19 by Constructing a Comorbidity Network with Central Nervous System Disorders
    Jing Qian, Bin Yang, Shuo Wang, Su Yuan, Wenjing Zhu, Ziyun Zhou, Yujuan Zhang, Guang Hu · 2024 · International Journal of Molecular Sciences
  31. Discovering novel cancer bio-markers in acquired lapatinib resistance using Bayesian methods
    AKM Azad, Salem A. Alyami · 2021 · Briefings in Bioinformatics
  32. Evidence-based approach to early outpatient treatment of SARS-CoV-2 (COVID-19) infection
    J. Drew Payne, Kimberly Sims, Cynthia Peacock, Tanis Welch, Ruth Berggren · 2021 · Baylor University Medical Center Proceedings
  33. The Circadian Clock, the Brain, and COVID-19: The Cases of Olfaction and the Timing of Sleep
    Rachel S. Herz, Erik D. Herzog, Martha W. Merrow, Sara B. Noya · 2021 · Journal of Biological Rhythms
  34. Tratamiento con melatonina pre-pandemia por trastornos del sueño e infección por COVID-19. Estudio de corte transversal, retrospectivo
    Stella Maris Valiensi, Agustín Leandro Folgueira, Vanesa Antonella Vera, Agustín González Cardozo, Daniel Pedro Cardinali, Marcelo Francisco Rugiero · 2022 · Vertex Revista Argentina de Psiquiatría
  35. A Network-based Deep Learning Framework Catalyzes GWAS and Multi-Omics Findings to Biology and Drug Repurposing for Alzheimer’s Disease
    Jielin Xu, Yuan Hou, Yadi Zhou, Ming Hu, Feixiong Cheng · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Structurally-informed human interactome reveals proteome-wide perturbations by disease mutations
    Dapeng Xiong, Yunguang Qiu, Junfei Zhao, Yadi Zhou, Dongjin Lee, Shobhita Gupta, Mateo Torres, Weiqiang Lü, Siqi Liang, Jin Joo Kang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Pattern Recognition Algorithms in Pharmacogenomics and Drug Repurposing—Case Study: Ribavirin and Lopinavir
    Hiram Calvo, Diana Islas-Díaz, Eduardo Hernández-Laureano · 2025 · Pharmaceuticals
  38. An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis
    Luca Menestrina, Maurizio Recanatini · 2022 · Artificial Intelligence in the Life Sciences
  39. Systematic comparison of differential expression networks in MTB mono-, HIV mono- and MTB/HIV co-infections for drug repurposing
    Yao Jiang, Jiaxuan Zhang, Rong Liu · 2022 · PLoS Computational Biology
  40. Cynomolgus-rhesus hybrid macaques serve as a platform for imprinting studies
    Zongyang Lu, Jie Li, Yong Lu, Ling Li, Wei Wang, Chenchen Zhang, Libing Xu, Yanhong Nie, Changshan Gao, Xinyan Bian et al. · 2023 · The Innovation
  41. The Role of Artificial Intelligence and Machine Learning for the Fight Against COVID-19
    Andrés Iglesias, Akemi Gálvez, Patricia Suárez · 2023 · Springer optimization and its applications
  42. Underestimated virus impaired cognition-more evidence and more work to do
    Maher Un Nisa Awan, Faisal Mahmood, Xiao-bin Peng, Fenshuang Zheng, Jun Liang Xu · 2025 · Frontiers in Immunology
  43. Poking COVID-19: Insights on Genomic Constraints among Immune-Related Genes between Qatari and Italian Populations
    Hamdi Mbarek, Massimiliano Cocca, Yasser A. Al-Sarraj, Chadi Saad, Massimo Mezzavilla, Wadha Al‐Muftah, Dario Cocciadiferro, Antonio Novelli, Isabella Quinti, Azza Al-Tawashi et al. · 2021 · Genes
  44. A survey of the use of EHR as real-world evidence for discovering and validating new drug indications.
    N. Talukdar, Xiao-Dan Zhang, S. Paithankar, Hui Wang, Bin Chen · 2025 · Drug Discovery Today
  45. Counter Intituive COVID-19 Propagation Dynamics in Brazil
    Manuel Graña, Goizalde Badiola-Zabala, José Manuel López-Guede · 2021 · Lecture notes in computer science
  46. Classification and severity progression measure of COVID-19 patients using pairs of multi-omic factors
    Teng Chen, Paweł Polak, Stan Uryasev · 2022 · Journal of Applied Statistics
  47. AI for Drug Repurposing in the Pandemic Response
    Anh T. L. Truong, Agata Blasiak, Mathias Egermark, Dean Ho · 2022 · Springer eBooks
  48. Melatonin as adjuvant treatment in COVID-19 patients. A meta-analysis of randomized and propensity matched studies
    Krisztina Tóth, Eros Pilia, Giovanni Landoni, Davide Oreggia, Salvatore Giacomarra, Rosario Losiggio, Giacomo Maiucci, Iliyan Vlasakov, Andrey G. Yavorovskiy, Valery V. Likhvantsev et al. · 2023 · Signa Vitae
  49. Comparative analysis on artificial intelligence methods for DTI and DTBA prediction in drug repurposing
    Sheo Kumar, Amritpal Singh · 2025 · Medicinal Chemistry Research
  50. Precision Medicine Through Network Language: Integrating Clinical Insight and Data Expertise
    Maria Concetta Palumbo, Lorenzo Farina, Manuela Petti · 2026 · Genes
  51. Towards Network Medicine: Implementation of Panomics and Artificial Intelligence for Precision Medicine
    Robert D. Barber, Keith Kroeger · 2022 · Healthcare delivery in the information age
  52. Integrative and Complementary Medicine in Psychiatry
    Jerome J. Sarris, Patricia L. Gerbarg, Richard P. Brown, Philip R. Muskin · 2023 · Springer eBooks
  53. Integrative and Complementary Medicine in Psychiatry
    Jerome J. Sarris, Patricia L. Gerbarg, Richard P. Brown, Philip R. Muskin · 2024 · Springer eBooks
  54. SARS-CoV-2 in Asthmatic Children: Same Consequences in Different Endotypes?
    Alice Bosco, Vassilios Fanos, Serena Bosone, Valeria Incandela, Federica La Ciacera, Angelica Dessì · 2025 · Metabolites
  55. Pharmacological and philosophical considerations for the around-the-clock use of scheduled melatonin to promote sedation and reduce aggression in individuals with serious mental illness: a case report
    Kaitlyn E. Starr, Kimberly Burns, Tammie Lee Demler · 2021 · International Clinical Psychopharmacology
  56. HuCoPIA: An Atlas of Human vs. SARS-CoV-2 Interactome and the Comparative Analysis with Other Coronaviridae Family Viruses
    Naveen Duhan, Rakesh Kaundal · 2023 · Viruses
  57. Multimodal Single-Cell Omics Analysis of COVID-19 Sex Differences in Human Immune Systems
    Yuan Hou, Yadi Zhou, Michaela Ulrike Gack, Justin Durla Lathia, Asha R. Kallianpur, Reena Mehra, Timothy An-thy Chan, Jae Ung Jung, Lara E. Jehi, Charis Eng et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Network-based prediction and functional validation of metformin for potential treatment of atrial fibrillation using human inducible pluripotent stem cell-derived atrial-like cardiomyocytes
    Jessica C. Lal, Yadi Zhou, Shamone R. Gore-Panter, Julie H. Rennison, John Barnard, David R. Van Wagoner, Feixiong Cheng, Mina K. Chung · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Evaluation of the Efficacy of Omega-3 Fatty Acids Formulations in the Lipopolysaccharide-Induced Acute Lung Inflammation Rat Model
    Chandrashekhar Kocherlakota, Nagaraju Banda, Arjun Narala, Akula Srinath, Kumar S.D. Kothapalli, James Thomas Brenna · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  60. A computer simulation-based study on the intervention of active ingredients of Mongolian medicine into the S-protein of SARS-CoV-2-associated variant Omicron
    Lidao Bao, Jiuwang Yu, Mr Morigentu, Xuhong Tian, Chenxu Zhai, Jiu Jin, Xiaodong Zhang, Fengchun Wang, Zhaoxin Yang, Jiahui Qin et al. · 2022 · ChemRxiv
  61. Fármacos potencialmente útiles en el tratamiento de la COVID-19 en Atención Primaria
    L. García-Matarín, S. Velilla-Zancada, Eva Trillo‐Calvo, F. Molina-Escribano, A. Serrano-Cumplido · 2021 · Medicina de Familia SEMERGEN
  62. Learning COVID-19 network from literature databases using core decomposition
    Yang Guo · 2021 · UVic’s Research and Learning Repository (University of Victoria)
  63. Melatonin effects in COVID-19
    Andrey Valerievich Budnevsky, Sergey Nikolaevich Avdeev, Е. S. Ovsyannikov, В. В. Шишкина, Любовь Николаевна Антакова · 2021 · Russian Journal of Preventive Medicine
  64. Hubungan Antara Stress Kerja dan Kualitas Tidur Dengan Subjective Well-Being pada Dosen Uhamka Selama Pandemi Covid-19
    Anissa Rizky Andriany, Mahesti Pertiwi · 2021 · Syntax Idea
  65. Analysis of receptors responsible for the dysfunction of the human immune system by different viral infections
    Sergey M. Ivanov, Olga A. Tarasova, Vladimir Poroikov · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Major clinical outcomes of melatonin use in COVID-19 patients: a systematic review
    Mariana Tolentino Chaves, Ana Paula Tolentino Chaves · 2022 · International Journal of Nutrology
  67. Transcriptomics-Based Network Medicine Discovery and Population-Based Validation Identifies Metformin as a Candidate Drug for Atrial Fibrillation
    Jessica C. Lal, Chengsheng Mao, Yadi Zhou, Shamone R. Gore-Panter, Julie H. Rennison, Beth S. Lovano, Laurie Castel, Jiyoung Shin, Alan Marc Gillinov, Jonathan D. Smith et al. · 2022 · SSRN Electronic Journal
  68. Multi-layer guilt-by-association-based drug repurposing by integrating clinical knowledge on biological heterogeneous networks
    Dongmin Bang, Sangsoo Lim, Sangseon Lee, Sun Kim · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Identification of targets for drug repurposing to treat COVID-19 using a Deep Learning Neural Network
    Si-Han Wang, Yu‐Hsuan Tang, H.-Y Hsu, Chu-Nien Yu, Oscar Kuang‐Sheng Lee · 2023 · medRxiv
  70. Clinical Characteristics and Outcomes of All Three COVID-19 Waves: A Single-center Experience
    Suchira Chillana, Kapil Alias Mohit Chilana, Abinav Dagar, Nandan Putti · 2023 · Indian Journal of Respiratory Care
  71. Network medicine in precision cardio-oncology
    Michelle Z. Fang, John Rickards, Feixiong Cheng · 2025 · Elsevier eBooks
  72. Additional file 1 of Co-distribution of Light At Night (LAN) and COVID-19 incidence in the United States
    Yidan Meng, Vincent Zhu, Zhu, Yong · 2021 · Figshare
  73. Additional file 1 of An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection
    Azadeh Safarchi, Shadma Fatima, Zahra Ayati, Fatemeh Vafaee · 2021 · Figshare
  74. Additional file 5 of Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
    Yadi Zhou, Xu, Jielin, Hou, Yuan, James B. Leverenz, Asha R. Kallianpur, Mehra, Reena, Yunlong Liu, Yu, Haiyuan, Pieper, Andrew A., Jehi, Lara et al. · 2021 · Figshare
  75. Additional file 1 of Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
    Yadi Zhou, Xu, Jielin, Hou, Yuan, James B. Leverenz, Asha R. Kallianpur, Mehra, Reena, Yunlong Liu, Yu, Haiyuan, Pieper, Andrew A., Jehi, Lara et al. · 2021 · Figshare
  76. Survey on Deep Learning Methods in Drug Repurposing
    Ahmed Abo Elsoud, Mahmoud Mounir, Walaa Khaled Gad, Nagwa L. Badr · 2025 · International Conference on Intelligent Computing and Information Systems (ICICIS)
  77. Comparative analysis of 16S rRNA of bacteria associated with the ancient annelid Platynereis dumerilii: structural conservation across clades
    Jae Ann Buenaluz, Wilhelm M. Javier, Eleanor S. Austria, Mary Jhane G. Valentino · 2026 · Journal of Applied Biological Sciences
  78. THE COVID-19 CATALYST: A CRITICAL REVIEW OF ACCELERATED DRUG REPURPOSING STRATEGIES, LESSONS LEARNED, AND FUTURE DIRECTIONS
    Pedireddi Sobitha Rani, PULLA UDAYA CHANDRIKA, G. SUSMITHA, Lakshmi Devi Gottemukkula, MOHD ABDUL HADI · 2026 · International Journal of Applied Pharmaceutics
  79. EFFECTS OF MELATONIN IN DISEASES OF THE DIGESTIVE SYSTEM. LITERATURE REVIEW
    Akbota Skenderova, A. Oshibayeva, G.N. Nuskabayeva, U.B. Tatykayeva, М.U. Аnartayevа, G.Zh. SARSENBAYEVA, K.S. Kemelbekov, Aizat Seidakhmetova, Sandugash N. Alipbekova · 2026 · Ġylym men densaulyķ saķtau.
  80. Multilayered Prioritization of Graph Attention Autoencoder–Derived Drug Repurposing Candidates for COVID-19
    Yusuke Nakayama, Shingo Tsuji, Koji Yamamoto, Juran Kato-Suzuki, Kouichi Hosomi · 2026 · Pharmaceuticals
  81. Artificial intelligence and computational tools in drug repurposing: a new frontier in therapeutic discovery
    Amtul Muqeet Rafia, Fathima Begum, Billa Yashaswi, C. Sai Manasa, Durgam Akshaya · 2026 · International Journal of Community Medicine and Public Health